Korys appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the Huizingen. The venture was found in Europe in Belgium.
We also calculated 8 valuable employees in our database.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Korys, startups are often financed by PMV, Gilde Healthcare, Van Herk Ventures. The meaningful sponsors for the fund in investment in the same round are PMV, Debiopharm Group, Beringea. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, EASME - EU Executive Agency for SMEs.
The higher amount of exits for fund were in 2016. Comparing to the other companies, this Korys performs on 8 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 38 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity.
For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Renewable Energy. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Agendia, Amphivena Therapeutics, Greenbyte AB
Funds with similar focus
|BDPME||France, Ile-de-France, Paris|
|Cobalt Networks||California, Mountain View, United States|
|Heyong Touzi||China, Fujian, Xiamen|
|IDEA Northeastern University's Venture Accelerator||Boston, Massachusetts, United States|
|InvestCare Partners||Farmington Hills, Michigan, United States|
|Medtech Syndicate Nominee||-|
|Peak State Ventures||California, San Francisco, United States|
|Polar Capital Holdings||England, London, United Kingdom|
|Redwood Partners||New York, New York, United States|
|RHM Ventures LLC||North Carolina, Raleigh, United States|
|Roularta Media Group||Belgium, West Flanders, West-Vlaanderen|
|Spangler Financial Group||-|
|Start'Act||Gabès, Tunis, Tunisia|
|SZZT Electronics||China, Guangdong Province, Huizhou|
|Ventura Family Office||Buenaventura, Colombia, Valle del Cauca|
|Venture Frogs||California, San Francisco, United States|
|Victory Capital||Brooklyn, Ohio, United States|
|$40M||14 Sep 2022||Nashik, Maharashtra, India|
|$17M||09 Jun 2022||The Netherlands, Utrecht, Netherlands|
|$15M||28 Jan 2022||Utrecht, Utrecht, Netherlands|
|$6M||02 Sep 2021||-|
|$11M||30 Jul 2021||Munich, Bavaria, Germany|
|$4M||26 Mar 2021||Utrecht, Utrecht, Netherlands|
|$14M||21 Jan 2021||Leuven, Flemish Brabant, Belgium|
|$50M||13 Nov 2020||Boulder, Colorado, United States|
|$5M||16 Oct 2020||Coimbra, Centro, Portugal|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.